Markets
BSE See NSE See 26,747.83
53.55 (0.2%)
collapse Related Readings collapse

US FDA’s Alert On Wockhardt: Much Ado About Nothing?

| 5/30/2013 9:02 PM Thursday

Pharma giant Wockhardt has received a strong setback after the US FDA sounded an alert on its Waluj manufacturing facility, after which the stock was hammered by more than 25 per cent in just two trading sessions. The market, however, seems to be overreacting to these developments. Shrikant Akolkar tells us more.

One of the worst things to happen to any stock is for it to get hit by factors which are apparently serious but on deeper exploration seem to be routine. This happens chiefly due to investors’ knee-jerk reaction to news flows which creates humongous negativity around it. One company which has recently been hit by this syndrome is Wockhardt.

We had recommended Wockhardt in DSIJ Vol. 28, Issue # 9 (dated 21 April, 2013) in our cover story ‘Cherry Picking’. The scrip was severely hammered following the recent US FDA alert on its manufacturing facility located in Waluj, Aurangabad district of Maharashtra. In just two trading sessions alone (May 23 and 24, 2013) it lost more than 25 per cent in value. Currently, the stock is down 35 per cent from where we had recommended it. Investors who have acted on our advice would surely be jittery in the wake of such a slide in the stock’s price. What should their future course in this counter be? Should one sell and book losses or wait out the depression? Here are the answers that you would be looking out for.

To start with, the hammering of the stock was a knee-jerk reaction arising out of fears fuelled by a particular event. This fear was accentuated by many other factors that were external to the company. The principal factor among these was the developments in Ranbaxy earlier in the same week.

Ranbaxy, the pharma company now owned by Daichhi Sankyo, pleaded guilty before the United States Department of Justice on compliance related issues in two of its manufacturing facilities. This was in any case weighing heavily on pharma stocks. The alert on Wockhardt’s Waluj facility came immediately after this, and dampened the sentiment on the stock.

What is worth noting is that Ranbaxy had ignored earlier malpractices, the consequences of which it had to bear. Wockhardt, however, had invited the US FDA team to audit its new injectables unit at Waluj. This is what differentiates between the two companies.

Find More Articles on: DSIJ Magazine, Special Report, Stock Recommendations, Fundamental Picks, Product, Large Cap

«« First « Previous |1 2 | Last ››

DSIJ
Mindshare

Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Following stocks are close to their 52-week low as at 12.15 p.m. on December 9.

Beneficiaries of the cashless mantra trade higher on bourses

Beneficiaries of the cashless mantra trade higher on bourses

There are a host of stocks which are likely to benefit from the governments' big Digital push. These stocks have already seen a big run-up, post demonetisation. However, more upside is left in the stocks.

Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

The markets on December 9 opened up. BSE Sensex is trading at 26779.11, up by 84.83 points and the Nifty is trading at 8266.65, up by 19.80 points. Meanwhile, following stocks are close to their 52 week high as on December 9.

Banco Products runs low after rollback of buyback

Banco Products runs low after rollback of buyback

Banco Products’ board of directors have decided to drop the proposal of buyback of equity shares of the company and decided not to further proceed with the proposal.

Quarterly Result: Jindal Steel & Power Ltd

Quarterly Result: Jindal Steel & Power Ltd

Jindal Steel & Power Ltd., is currently trading at Rs. 73.95, up by 0.85 points or 1.16% from its earlier closing of Rs. 73.1 on the BSE. The company's net loss for the quarter stands at Rs 745.98 cr against Rs 909.53 cr.

Markets @ 11 am: Movers and Shockers

Markets @ 11 am: Movers and Shockers

Following are the top gainers and losers as of December 9. Intellect Design is the largest gainer; whereas MMTC is the largest loser. 

IL&FS Engineering & Construction Company shines on bagging REC order

IL&FS Engineering & Construction Company shines on bagging REC order

IL&FS Engineering & Construction Company (IL&FS ECC) has emerged as the lowest bidder for Rural Electrification Corporation (REC) works worth Rs 225 crore crore in Jharkhand. 

Sheela Foams IPO lists at a premium of 39%

Sheela Foams IPO lists at a premium of 39%

Maker of India’s most loved mattresses brand ‘Sleepwell’ has listed with a massive premium of close to 39 per cent on the bourses. The Rs 510-crore initial public offer was oversubscribed 5.09 times on December 1, the last day for subscription. The issue was opened on November 29.

Tanla Solutions hits new 52-week high

Tanla Solutions hits new 52-week high

Tanla Solutions has hit new 52-week high on December 9. The scrips are witnessing high volume with thirty day SMA of 40.85. The shares of the company which previously closed at Rs 49.95; opened at Rs 51.50 and as at 9.52 am are trading at Rs 57.35, up by 14.81 per cent.

Stock in focus: KPR Mill

Stock in focus: KPR Mill

KPR Mill, which had earlier proposed a buy-back has finally got approval from its board. The scrip of KPR Mill by default is expected to spice up. 

Market
CHIT CHAT

What is your view on markets today?

200  Characters Remaining.
Please LOGIN  to post your comments or Click here to go back.
Shubham Maheshwari Dec 09 12:58PM
Buy ugar sugar work for short term profit
MANISH TYAGI Dec 09 12:54PM
@rajiv Nice timing, swing on tara
VINAY HEGDE Dec 09 12:49PM
PASSWORD iA9u1LVE
rajiv jha Dec 09 12:44PM
Elnet tech for short term
rajiv jha Dec 09 12:43PM
Pincon spirit also good for long term

news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »